Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation
NCT02028650
·
clinicaltrials.gov ↗
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Relapse Leukemia
Interventions
BIOLOGICAL:
the first donor's stem cell
BIOLOGICAL:
the second donor's stem cell
Sponsor
huishengai